Author: Team

Conquer Hand, Foot and Mouth Disease: A Parent’s Toolkit

By-Dr. Sujatha Thyagarajan, Lead & HOD – Pediatric Intensive Care and Pediatric Emergency, Aster RV Hospital

 When your child feels unwell, the worry can be overwhelming. Among the common illnesses young children encounter is Hand, Foot, and Mouth Disease (HFMD). Although it’s often mild, understanding this illness, its symptoms, and how to care for your child can help make the experience less stressful.

 What is Hand, Foot, and Mouth Disease?
Infection with HFMD is caused primarily by a virus called coxsackie. It commonly affects children under seven years of age, especially toddlers, and is most prevalent during the summer and fall. HFMD should not be confused with foot-and-mouth disease, which affects animals. The name originates from its hallmark symptom—a rash that appears on the hands, feet, and inside the mouth.

 While HFMD is a self-limiting illness that resolves within 7–10 days, its symptoms can cause discomfort, especially for young children. The disease spreads easily through saliva, unwashed hands, and surfaces contaminated by bodily fluids. Schools, daycare centers, and playgrounds are common hotspots for outbreaks.

 Recognizing the Symptoms of HFMD
The symptoms of HFMD typically begin 3–5 days after exposure to the virus. Early signs include fever, sore throat, and a general sense of feeling unwell. Soon after, more specific symptoms develop:
Mouth Sores: Painful red spots or ulcers appear inside the mouth, often on the tongue and throat. These sores can make eating or drinking difficult, leading to irritability and dehydration.
Skin Rash: A rash of red spots, sometimes with small blisters, develops on the palms, soles, and other areas such as the buttocks and legs. The rash is usually not itchy but can be tender.
Other Symptoms: Some children may experience loose stools, drooling due to mouth pain, or a reduced appetite.
Most children recover with minimal complications, but dehydration and rare issues like viral meningitis or encephalitis (brain swelling) may occur in severe cases.

 How Does HFMD Spread?
HFMD is highly contagious and spreads easily in close-contact settings. The virus can be transmitted through saliva, nasal mucus, feces, and blister fluid. Children often become infected by touching toys or surfaces shared with others and then putting their hands in their mouths.

 The disease is contagious even before visible symptoms, such as a rash, appear and remain transmissible for several days. Good hygiene and proactive measures are essential to prevent its spread.

 Caring for a Child with HFMD
There’s no specific cure for HFMD, but you can manage your child’s symptoms to ensure comfort and prevent complications.

 Here are some practical tips for home care:

Soothing Foods and Fluids: Offer soft, non-acidic foods like yogurt, pudding, and pasta to reduce irritation in the mouth. Cold treats such as popsicles and smoothies can also help numb the pain. Ensure your child drinks plenty of fluids to stay hydrated, as dehydration is a common concern.
Skin Care: Keep blisters clean and avoid popping them. Wash affected areas gently with lukewarm soap and water. Avoid itching to prevent breaking of blisters that could risk secondary infection
Rest and Isolation: Allow your child to rest and recover at home. Keep them away from daycare or school until their fever subsides and they feel better.
Most children feel significantly better within a week, though the rash may linger longer.

 When to Call the Pediatrician
While HFMD is generally mild, certain symptoms require medical attention. The following symptoms should be reported to your child’s healthcare provider:
• Dark urine, dry mouth, and fewer wet diapers are all signs of dehydration.
• Fever lasting more than three days.
• Severe mouth sores that prevent your child from eating or drinking.
• Excessive fussiness, lethargy, or difficulty waking your child.
• Symptoms that persist beyond 10 days or worsen over time.
In rare cases, HFMD can lead to complications like viral meningitis, which requires prompt medical care. Always trust your instincts—if something feels off, don’t hesitate to seek help.

55 Years of Constitution Making: Dr. Narendra Jadhav Delivers Thought-Provoking Lecture on Dr. B.R. Ambedkar’s Role

Hyderabad, March 2025: Shri Narendra Damodar Jadhav, former Rajya Sabha Member, former Vice-Chancellor of Savitribai Phule Pune University, and former Chief Economist of the Reserve Bank of India; delivered the prestigious annual Justice Konda Madhava Reddy Memorial Lecture” organised by Justice Konda Madhava Reddy Foundation, on the topic “55 years of The Constitution Making and the Role of Dr. B.R. Ambedkar” on Saturday at AV College, Domalguda, Hyderabad. The event was presided over by Hon’ble Justice B. Sudarshan Reddy, former Supreme Court Judge, Shri Konda Vishweshwar Reddy, Member of Parliament, Chevella Constituency, was present on the occasion.

Shri Narendra Damodar Jadhav speaking on the occasion said, 55 years of The Constitution Making and the Role of Dr. B.R. Ambedkar, most people are baffled by the mention of 55 years of Constitution making, people believe that the Indian Constitution was written during the period 1946 to 1950, that was the period when the Constituent Assembly was working to create the constitution of India, However this statement is half-truth, in reality the India constitution was the outcome of 55 year long process of constitutional reforms starting way back in 1895, that is why it is 55. Do you know there were two parallel tracks of constitutional reforms one from the British Rulers and the second one from Indian Leaders. These two parallel tracks finally merged together in 1946, when the constituent assembly was formed, and it led to finally India becoming a democratic republic in January 1950. There were as many as 12 major attempts to make Indian Constitution. One leader who was common to most if not all of these 12 efforts, not Mahatma Gandhi, not Jawaharlal Nehru, not Sardar Patel, it was the indomitable Dr Babasaheb Ambedkar.

Justice B. Sudarshan Reddy, said, the constitution of India, was conceived as a framework for governance and social relations. It was shocking and deeply distressing to read about constitutional functionaries including some learned Supreme Court judges likening welfare recipients as parasites. To call welfare schemes freebees suggesting that the recipients are undeserving of the solicitude of our policy makers, it is an attempt to dehumanize our fellow citizens. It is something to be extremely concerned about.

Sri Gaddam Prasad Kumar, Hon’ble Speaker of the Legislative Assembly, Telangana, speaking on the occasion said, Late Justice Konda Madhav Reddy was a stalwart in the field of judiciary and a great scholar, he brought reforms in the field of education. The trust formed in his name has been doing great work such as free medical camps, improving sanitation in Government schools, working towards enhancing skills and youth employment generation.

Dr K. Lakshman, Member of Parliament Rajya Sabha, said, our constitution is one of the best constitutions provided by the architect of the constitution, Dr Baba Saheb Ambedkar. India is one of the biggest democratic countries in the world, and proud to add that India is the mother of democracy. Dr Ambedkar was committed and wanted to empower the downtrodden, weaker sections. We saw during the Constitution framing, right from day one Dr Baba Saheb Ambedkar was differing with Nehru ji on certain issues, whether it is Art. 370, Jammu Kashmir being a part of India. Being a visionary leader Dr Ambedkar has given such a beautiful constitution. We witnessed many such instances to disrupt our constitution like Emergency, abuse of Art. 356, but it survived all such attempts and became stronger.

Speaking on the occasion Shri Konda Vishweshwar Reddy said, in today’s global turmoil after 78 years of independence, the need to protect the unity and integrity of the nation is ever so important. We look at the constitution as the guiding light and beacon, to take India forward to a Vikasit Bharat. This memorial lecture is a tribute to the legacy of Justice Konda Madhav Reddy, we gathered here to celebrate his contribution to the field of law and justice. Let us take a moment to remember his remarkable life and achievements. The Foundation in his name has been doing various charitable works and works that promote development in rural areas, specially focused on children, education through scholarship, skill development and job creations. Nehru wanted a separate constitution for Jammu Kashmir, separate assembly with full of powers, Ambedkar Ji was insisting for Hindu code bill and Nehru was never in favor, likewise there are many such issues.

Dr. Narendra Jadhav – A Scholar, Economist & Author

Dr. Narendra Jadhav has held key positions in India’s governance and economic landscape—serving as a Member of the Planning Commission, Chief Economist at the RBI, Vice-Chancellor of Pune University, and a distinguished Rajya Sabha Member. His contributions continue to shape India’s intellectual and policy discourse.

World Rare Disease Day 2025: Indian Organization for Rare Diseases Focuses on Policy and Awareness through Conference

Vijayawada, 3rd March 2025: The Indian Organization for Rare Diseases (IORD), a non-profit advocacy body, today convened a critical conference titled “RAISE THE AWARENESS – RARE DISEASES: Advocate Public Policy, Promote Diagnosis, Treatment & Social Services” at Fortune Murali Park, Vijayawada, to mark World Rare Disease Day 2025.

The event, attended by healthcare experts, policymakers, and patient advocates, spotlighted the urgent need for systemic interventions to address the challenges faced by over 90 million Indians and 300 million individuals globally living with rare diseases.

Chief Guest Sri M.T. Krishna Babu, IAS, Special Chief Secretary for Health, Medical & Family Welfare, Government of Andhra Pradesh; speaking after inaugurating the Raise The Awareness – Rare Diseases hosted by The Indian Organization for Rare Diseases; said, The Indian Organisation for Rare Diseases (IORD) President and CEO, Prof. Ramaiah Muthyala Garu, has put in tremendous effort in the field of rare diseases. His passion and dedication to this cause are truly commendable. We are honored to be associated with this noble initiative. We extend our heartfelt congratulations and appreciation to Prof. Ramaiah Garu and his team for their sincere efforts in raising awareness about the prevalence of rare diseases and bringing stakeholders together on a common platform to explore the best possible solutions. As Prof. Ramaiah Garu has already emphasized, while we cannot reverse the past or cure all rare diseases, we can certainly create an environment that provides comfort and dignity to those affected.

The World Health Organization (WHO) estimates that 65 people in one lakh people are affected by rare diseases. However, statistics indicate that nearly 5% of the population suffers from some form of rare disease. While some of these conditions are partially treatable, others require lifelong treatment, often with expensive medications. In 2021, the Government of India introduced the National Policy for Rare Diseases, which provides a structured approach to addressing these conditions. Under this policy, individuals can register at one of the 12 designated Centers of Excellence for Rare Diseases. However, given that India has a population of nearly seven to eight crore people affected by rare diseases, these centers alone are insufficient.

Every state government must formulate its own policy to address this pressing issue. Unfortunately, due to a lack of awareness and vocal representation from affected individuals, governments have not allocated substantial budgetary resources for rare disease treatments.

One key recommendation from the Indian Organisation for Rare Diseases is to establish a Center of Excellence for Rare Diseases in Andhra Pradesh. This would ensure that individuals with rare diseases receive proper guidance, registration, and benefits from the Rashtriya Arogya Nidhi (RAN) scheme, which provides up to ₹50 lakh worth of medicines for registered patients. Potential locations for this center include AIIMS Mangalagiri or King George Hospital (KGH), which is affiliated with the 100-year-old Andhra Medical College and has a strong presence of specialized and super-specialized departments. Although KGH has already been designated as a Center of Excellence for certain diseases, rare diseases require official notification from the Government of India. We will assess the necessary facilities and work towards securing this recognition, ensuring that Andhra Pradesh contributes effectively to the management of rare diseases.

The Indian Organisation for Rare Diseases is driven by dedicated and passionate individuals who are committed to this cause. I am confident that they will develop a practical strategy that enables the state government to take significant steps toward managing rare diseases effectively. We are eager to collaborate with IORD and its selfless team members, who tirelessly work for the well-being of disadvantaged individuals and their families. No family willingly wishes to deal with such challenges—it is beyond human control. However, it is our responsibility to manage these circumstances in the best possible way. Support must come not only from the government but also from society at large. Once a practical plan is developed, we are ready to collaborate to bring solace to affected families.

Our honorable Andhra Pradesh Chief Minister, Shri N. Chandrababu Naidu, has emphasized the importance of genetic mapping. He has initiated a massive effort to conduct genome sequencing and develop a disease profile of the population using advanced genetic analytics. We hope that future efforts in identifying and registering affected individuals will help them access better medical care. Once a condition is diagnosed, we can plan further steps, such as identifying available treatment facilities, facilitating sponsorships, and coordinating with relevant organizations to ensure quality healthcare.

I sincerely hope that the two decades of hard work by the Indian Organisation for Rare Diseases will bear significant fruit in the coming years. I urge the members to continue their efforts with the same enthusiasm and take this campaign forward. The government will do its best to support and strengthen these initiatives. Thank you for organizing this meeting in Vijayawada for the second time. Being from a Telugu-speaking state, you bring a special passion to this cause, and we are confident that your presence will be instrumental in helping Andhra Pradesh take a leading role in rare disease management.

Global and National Crisis

With over 7,000 identified rare diseases impacting 5% of the world’s population, patients in India grapple with delayed diagnosis, scarce treatments, and exorbitant healthcare costs. In Andhra Pradesh alone, thousands remain undiagnosed or untreated due to limited infrastructure and awareness. Extrapolating from the 2021 census data, Andhra Pradesh’s population is approximately 5.27 crore (52.787 million).

Assuming a 5% prevalence of rare diseases, the estimated rare disease population in Andhra Pradesh is approximately 26.39 lakh.

Key Recommendations for Andhra Pradesh

The conference outlined six actionable proposals for the Andhra Pradesh Health Ministry to transform rare disease care:

1. Establish a Centre of Excellence (CoE): Upgrade AIIMS Mangalagiri as a Centre of Excellence for rare disease treatment, leveraging central funds to enhance access to specialized care.

2. State-Funded Rare Disease Centre: Provide genetic counselling, subsidized testing, and a toll-free helpline under existing health schemes.

3. Statewide Rare Disease Survey: Train Anganwadi workers to conduct a pilot survey, enabling data-driven policy formulation. IORD would be glad to facilitate the training.

4. National Family Health Survey (NFHS) Inclusion: Advocate adding rare disease questions to NFHS-6 for rare disease prevalence mapping in the state.

5. District-Level Coordination Committees: Streamline referrals and central funding access for Rs. 50 lakh/patient under Rashtriya Arogya Nidhi.

6. Centralized Drug Procurement: Negotiate bulk purchases of therapies like enzyme replacements to reduce costs for rare disease patients.

Sri Satya Kumar Yadav, Hon’ble Minister for Health, Andhra Pradesh, emphasized, who could not be physically present in view of the assembly session, said “We are committed to evaluating IORD’s proposals to build an inclusive healthcare framework.”

Dr. Ramaiah Muthyala, IORD President, added, “Andhra Pradesh has the potential to lead India in rare disease care. Prioritizing these steps will save lives and set a national benchmark.” While submitting a memorandum to the Sri M.T. Krishna Babu, IAS, Special Chief Secretary, Health Medical & Family Welfare, Govt. of Andhra Pradesh, Dr Ramaiah Muthyala requested the Andhra Pradesh government to take up actionable steps for the betterment of rare disease community.

In his address, Sri M.T. Krishna Babu, IAS, Special Chief Secretary, Health Medical & Family Welfare, Govt. of Andhra Pradesh, promised a slew of healthcare measures for rare disease community in the state besides listing out several steps the AP government has already initiated. He said that the AP government would initiate steps to provide affordable medications/drugs for rare disease patients by seeking a list of such drugs from Director of Medical Education, AP. He also promised to seek a Centre of Excellence for Rare Diseases designated by the Centre either at AIIMS Mangalagiri or Andhra Medical College, KGH besides utilizing the services of ASHA and ANM health workers for creating awareness and identification of rare disease patients. Please check the full video for his speech.

Some of the actionable steps for rare disease community listed by him included roping in Anganwadi and ASHA workers and utilising health workers for gathering rare disease date through National Family Health Survey in the state.

National Institution for Transforming India (NITI) Aayog member Dr. Vinod K. Paul, Member, in his video address to the participants, presented significant developments in India’s approach to rare diseases. The government has prioritized treatment for 13 rare disorders, including both small molecule drug treatments and complex therapies. Please check his video address.

Healthark Presents Key Insights in a Landmark Report on Life Sciences Healthcare Maturity

Hyderabad, March 2025- Healthark today launched its latest industry report, Expanding Horizons – The Maturity Journey of Life Sciences and Healthcare GCCs in India, at BioAsia 2025. The report provides an in-depth analysis of the evolution, functional maturity, and future opportunities for Life Sciences and Healthcare (LSHC) Global Capability Centers (GCCs) in India.

Over the past two decades, India has emerged as a global hub for LSHC GCCs, growing from a handful of captive centers in 2005 to over 100 today. The report highlights India’s strategic advantages in talent, infrastructure, and innovation-driven growth. Initially established as in-house service providers for IT, back-office operations, and early R&D support, these centers have since expanded their capabilities to include regulatory submissions, early-stage clinical trials, and molecule screening.

The report also outlines how, as the sector has matured, GCCs have moved up the value chain, playing a critical role in drug development. A highly skilled tech ecosystem has enabled high-value IT transitions, allowing these centers to contribute strategically to their parent organizations. With a strong emphasis on digital transformation, many GCCs are now leading open and closed innovation initiatives, establishing Centers of Excellence (CoEs), and enhancing global business functions.

Geographically, Hyderabad, Bengaluru, Mumbai, Delhi-NCR, Chennai, and Pune collectively account for more than 95% of India’s LSHC GCCs. Hyderabad alone hosts over 20%, with global companies increasingly setting up second facilities or expanding operations due to the city’s mature ecosystem and strong government support. The study underscores that establishing GCCs in India offers 40%-50% cost savings, driven by lower operational costs, real estate affordability, and competitive salaries.

“As Hyderabad cements its position as a leading hub for LSHC GCCs, our government remains committed to fostering innovation and supporting the sector’s continued expansion,” said Hon’ble Minister for Industries and Commerce, Government of Telangana, Sridhar Babu. “The city’s deep talent pool, advanced infrastructure, and progressive policies make it an attractive destination for global players.”

Jayesh Ranjan, Special Chief Secretary, Government of Telangana noted, “the rapid growth of LSHC GCCs in Hyderabad reflects the city’s strong biotech and pharma ecosystem. The expansion of global players and the establishment of new centers reinforce India’s growing role in the global life sciences value chain.”

More than 50% of LSHC GCCs in India now focus on core and support drug development activities, while 60% engage in business operations spanning commercial, supply chain, and corporate functions such as Finance & Accounting and HRM. Technology remains the most mature function, with over 80% of GCCs involved in platform engineering and digital transformation, reinforcing India’s status as a global tech powerhouse.

“India’s LSHC GCCs have evolved beyond cost arbitrage to become strategic hubs driving innovation, digital transformation, and complex business functions,” said Sudeep Krishna, Co-Founder & President, Healthark. “This report showcases the incredible maturity journey of these centers and their potential for global impact.”

Looking ahead, the report identifies key opportunities for GCCs in India, emphasizing the importance of housing global product owners to drive end-to-end product development and R&D operations. Establishing Global Process Owners (GPOs) is seen as essential for achieving standardization across workstreams and ensuring a sustainable competitive advantage. Additionally, adopting an optimized sourcing strategy—balancing core activities within the company while outsourcing non-core operations—will be crucial for maximizing efficiency and scalability.

“The next phase of growth for LSHC GCCs will be driven by enhanced product development capabilities, differentiated talent strategies, and the adoption of best-in-class sourcing models. India is well-positioned to lead this transformation”, said Dr. Purav Gandhi, Founder & CEO, Healthark.

‘An Integral Part of My Journey’: Tarun Khanna on Playing Lord Shiv in Sony SAB’s Veer Hanuman

Celebrated artist Tarun Khanna joins the stellar cast of Sony SAB’s much-anticipated devotional epic Veer Hanuman , as he steps into the revered role of Lord Shiva for the 11th time. Premiering on 11 th March at 7.30 pm, the mythological saga brings to life the remarkable story of Lord Hanuman, and his journey from a young boy to the revelation of his powers. With its compelling storyline and dynamic characters, this show promises to enthrall and inspire audiences, taking them on a transformative spiritual adventure.

Actor Tarun Khanna is no stranger to mythological roles, with his recent stint on Shrimad Ramayan where he also portrayed the character of Shiv ji, impressing audiences. His experience in the genre brings the ability to elevate every role he portrays, and his performance in Veer Hanuman promises to resonate with audiences as Lord Hanuman is believed to be a Shiv Ansh (incarnation of Lord Shiva).

On the occasion of Mahashivratri, Tarun Khanna shared, “Bringing Lord Shiva to life is always an honor, but “Veer Hanuman” is truly special. Exploring the profound connection between Shiva and Hanuman adds a whole new dimension, making this portrayal incredibly powerful and moving. I can’t wait for audiences to experience that divine energy and connect with it on a spiritual level.”

Renowned actor Tarun Khanna has joined the stellar cast of Sony SAB’s much-awaited spiritual saga ‘Veer Hanuman’. He will be playing the iconic role of Lord Shiva for the 11th time in the show. Airing from 11th March at 7:30 pm, the mythological serial will trace the amazing journey of Lord Hanuman’s life – from a child to the revelation of his divine powers. Packed with an intriguing storyline and strong characters, the show promises to take the viewers on a spiritual and inspirational journey.

Tarun Khanna is not new to mythological characters. Recently, he impressed the audience by playing the role of Lord Shiva in ‘Srimad Ramayan’. His deep understanding of this genre brings every character alive. His presence in ‘Veer Hanuman’ is very special, because Hanuman ji is considered to be Shiv Ansh (incarnation of Lord Shiva).

Tarun Khanna said on the occasion of Mahashivratri “It has always been an honour for me to bring Lord Shiva to life, but ‘Veer Hanuman’ is truly special for me. This show has given me the opportunity to explore and present the deep connection between Shiva and Hanuman, which makes it even more powerful and emotionally deep. I am confident that the audience will feel this divine energy and will be able to absorb it spiritually.”

PV Sindhu Paves the Way for Change with Himalaya’s Muskaan Initiative

Hyderabad, 3rd March 2025: A smile is more than just an expression—it’s a child’s first step toward confidence. Yet, thousands of children in India are born with cleft conditions that hinder their ability to eat, speak, and smile freely. Since 2016, Himalaya Wellness Company’s initiative, Muskaan, has been transforming lives by providing comprehensive cleft care and supporting free cleft lip surgeries across the country. Now, Muskaan takes a bold step forward with celebrated badminton champion PV Sindhu, who joins forces with Himalaya and Smile Train India to amplify awareness and ensure more children receive life-changing treatment.

Known for her commitment to social causes, Sindhu has been a strong advocate for empowering children and ensuring their overall well-being. Her association with Muskaan further strengthens the initiative’s reach, inspiring people to contribute to this noble cause. By lending her voice and platform, Sindhu aims to raise awareness not only about the need for cleft treatment but also about the broader health challenges faced by children with cleft conditions, such as difficulties in getting proper nutrition, speech, and overall development. Through this initiative, she hopes to ensure that every child receives the comprehensive care they need to lead a healthier and more confident life.

Speaking at the event held in ITC Kohenur, Hyderabad, Olympic medallist PV Sindhu expressed her support to the cause, emphasizing how confidence plays a crucial role in shaping a child’s future. “Confidence shapes a child’s future—it gives them the courage to chase their dreams and face the world without hesitation. Every child deserves that strength, and access to cleft care plays a vital role in ensuring they can grow up without limitations. I am truly honoured to support Himalaya’s Muskaan initiative, which is making a real difference by providing children with the treatment they need. By raising awareness, we can empower more children with the confidence to thrive. I encourage everyone to join us in spreading the word and making a difference.”

The event featured an engaging panel discussion with Rajesh Krishnamurthy, Business Director, Consumer Products Division, Himalaya Wellness Company, and Mamta Carroll, Senior Vice President & Regional Director for Asia, Smile Train. They shed light on the importance of early cleft intervention and the growing impact of Muskaan over the years. Since its inception in 2016, the initiative has facilitated over 2,000 free cleft surgeries across 600+ districts in India.

Rajesh Krishnamurthy, Business Director, Consumer Products Division, Himalaya Wellness Company, said, “At Himalaya, we believe that wellness goes beyond products—it is about making a meaningful difference in people’s lives. With PV Sindhu’s support, we aim to reach even more families to ensure that every child gets the opportunity to smile confidently. Our vision of ‘Wellness in every home, Happiness in every heart’ is deeply connected to this initiative, and we are grateful to be able to continue making a lasting impact.”

Emphasizing the need for timely treatment, Mamta Carroll, Senior Vice President & Regional Director for Asia, Smile Train, added, “Timely cleft treatment not only restores a child’s smile but also ensures they can lead a healthy and fulfilling life. Awareness plays a critical role in bridging the gap between children in need and life-changing cleft care. With Himalaya’s continued commitment and PV Sindhu’s support, we hope to reach even more families and ensure that no child has to live with an untreated cleft.”

Through her role in Muskaan, PV Sindhu will help drive widespread awareness, encourage public participation, and reinforce the importance of timely cleft treatment. With her support, Himalaya and Smile Train India are optimistic about extending their outreach and inspiring more people to join this growing movement.

National Science Day Performance ‘There is No Planet B’ Drives Awareness and Action

Thane, 03rd March 2025 – Korum Mall, a leader in sustainability-driven initiatives, successfully hosted an inspiring science awareness campaign in collaboration with Nalanda Public School on National Science Day. Eighty young visionaries from Grade 7 took the stage to deliver a thought-provoking performance on the urgency of climate action. With students from Grade 6, parents, and mall shoppers in attendance, the play served as a wake-up call for a sustainable future.

Bringing science to life, the event made learning interactive and engaging. Through live performances, students demonstrated how the Earth has evolved. They further stressed how human intervention has slowly degraded Earth and inspired young minds to be proactive in saving our planet. A street march led by students further emphasized sustainability and environmental conservation, perfectly aligning with Korum Mall’s commitment to these causes.

“The dedication of the students of Nalanda Public School was truly remarkable. Science is crucial in shaping a sustainable future, and this event ignited curiosity and awareness among children and adults alike,” — Mr. Deva Jyotula, Senior Vice President of Retail, KORUM MALL

Nalanda Public School also expressed appreciation for Korum Mall’s support. “We sincerely thank Korum Mall for being a valuable venue partner. Their commitment to sustainability and education provided an ideal platform for our students to showcase their creativity and spread awareness about climate action,” said [Mrs. Nandita Khanna], [Principal] of Nalanda Public School.

ISB Commemorates Graduation Day for PGP MAX, PGP PRO, PGP MFAB, and AMPBA Programs

[March 3, 2025]: The Indian School of Business (ISB) today celebrated the graduation of 505 students across PGP MAX Co2024, PGP PRO Co2024, PGP MFAB Co2024 and AMPBA Co2023 (Winter) and AMPBA Co2024 (Summer) programmes at the school’s Hyderabad campus. The graduation day commenced with the ceremonial procession led by the Dean of ISB, Chief Guest Shri Mahesh Kolli, Founder and Group President, Greenko Group, and senior faculty members of ISB.

In his address, Shri Mahesh Kolli urged the graduates to embrace the transformative opportunities that lay ahead of them. He emphasised the importance of cultivating strong beliefs, identifying megatrends, and fostering sustainable partnerships as essential pillars for impactful careers and entrepreneurial success. Kolli underscored that sustainability is not merely an environmental necessity, but a powerful economic opportunity, capable of driving growth through innovation.

Drawing from Greenko’s journey, he explained how integrating nature’s value into business models can unlock affordability and accessibility without compromising on environmental goals. Kolli concluded by inspiring the graduating class to lead with curiosity, creativity, and purpose in shaping a sustainable and prosperous future.

Professor Madan Pillutla, Dean, ISB, congratulated the graduating classes on their remarkable achievement of completing rigorous programmes, while balancing careers and personal commitments. The Dean also urged graduates to reflect on the knowledge and skills gained at ISB and use them not only for professional success, but also to create meaningful impact in their industries and communities. He encouraged the graduates to lead with kindness, address global challenges, and support those less fortunate. He also emphasised the need to be lifelong learners to stay relevant and achieve great success. He reaffirmed ISB’s pride in their accomplishments, pledging the school’s continued support as they move forward in their journeys.

Students from the Post Graduate Programme in Management for Working Professionals (PGP PRO Class of 2024-Hyderabad; Delhi; Mumbai and Bengaluru cohorts: 221; Post Graduate Programme in Management for Senior Executives (PGP MAX Class of 2024): 62; Post Graduate Programme in Management for Family Business (PGP MFAB Class of 2024): 59 and Advanced Management Programme in Business Analytics (AMPBA) Class of 2023 (Winter): 71 and Class of 2024 (Summer): 92 graduated today from ISB.

ISB celebrated academic and leadership achievements, wherein Scholar of Excellence awards were presented to outstanding students from each programme. The graduation ceremony also honoured faculty members and academic associates for their important role in the students’ learning journeys. The ceremony ended with graduates tossing their hats in celebration, joined by their jubilant families and friends.